Fred Cohen

Fred Cohen

Direktor/Vorstandsmitglied bei INTELLIA THERAPEUTICS, INC.

Vermögen: 7 Mio $ am 31.05.2026

69 Jahre
Health Technology
Finance
Commercial Services

Profil

Fred Ehrenkranz Cohen founded TPG Biotechnology Partners LP in 2001, where he worked as Managing Director & Partner from 2001 to 2016, Cell Design Labs, Inc. in 2016, where he worked as Chairman from 2016 to 2017, Vida Ventures LLC in 2017, where he worked as Senior Managing Director, and various other companies.
Dr. Cohen also currently works at Quintiles Transnational Corp., as Director, Acumen, Inc., as Director, Novotech (Australia) Pty Ltd., as Director, and various other companies.
Dr. Cohen also formerly worked at BioCryst Pharmaceuticals, Inc., as Independent Director from 2013 to 2019, Progyny, Inc., as Independent Director from 2015 to 2025, Kosan Biosciences, Inc., as Senior Director-Business Development, and various other companies.
Dr. Cohen received his doctorate degree in 1984 from Stanford University, doctorate degree in 1980 from the University of Oxford, and undergraduate degree in 1978 from Yale University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
12.06.2026 155.265 ( 0,3 % ) 4 Mio $ 31.05.2026
09.06.2026 216.653 ( 0,16 % ) 3 Mio $ 31.05.2026
05.06.2025 15.000 ( 0,03 % ) 421 950 $ 31.05.2026
27.05.2026 21.727 ( 0,04 % ) 185 114 $ 31.05.2026

Aktive Positionen von Fred Cohen

UnternehmenPositionBeginn
INTELLIA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 24.01.2019
KYVERNA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.01.2018
CAREDX, INC. Direktor/Vorstandsmitglied 01.01.2014
Direktor/Vorstandsmitglied -
Gründer 01.01.2017
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 02.12.2020
Novotech Aus Holdco Pty Ltd.
Direktor/Vorstandsmitglied 01.02.2018
░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Fred Cohen

UnternehmenPositionEnde
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Fred Cohen im Detail an

Ausbildung von Fred Cohen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

58

Beziehungen ersten Grades

58

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen58

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Consumer Services

Producer Manufacturing

Commercial Services

Miscellaneous

Commercial Services

Commercial Services

Health Technology

Finance

Finance

Health Technology

Matrix Pharmaceuticals, Inc.

Health Technology

National Academy of Medicine

Finance

Health Technology

Miscellaneous

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Finance

Health Technology

Acrostar Pharmaservices Corp.

Commercial Services

Novotech Aus Holdco Pty Ltd.

Health Technology

Health Technology

Finance

Health Technology

Finance

Health Technology

  1. Börse
  2. Insiders
  3. Fred Cohen